Autumn Glory Partners’s Amgen AMGN Stock Holding History

Autumn Glory Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	680 +3	+0.4%	+$1.03K	0.07%	194
2026 Q1	$238K	Buy	677 +31	+5%	+$11.1K	0.09%	189
2025 Q4	$211K	Buy	+646	New	+$205K	0.07%	196
2025 Q2	–	Sell	-646	Closed	-$201K	–	188
2025 Q1	$201K	Buy	+646	New	+$191K	0.1%	171
2024 Q4	–	Sell	-798	Closed	-$268K	–	174
2024 Q3	$268K	Buy	798 +152	+24%	+$49.7K	0.1%	179
2024 Q2	$202K	Buy	+646	New	+$190K	0.1%	169
2023 Q4	–	Sell	-836	Closed	-$225K	–	166
2023 Q3	$225K	Buy	+836	New	+$209K	0.14%	143
2022 Q1	–	Sell	-1,336	Closed	-$300K	–	149
2021 Q4	$300K	Buy	+1,336	New	+$282K	0.13%	163

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Autumn Glory Partners's AMGN Position: Q2 2026 in Review

Autumn Glory Partners increased its Amgen (AMGN) stake by 0.44% in Q2 2026, buying an estimated $1.03K and bringing the position to 680 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #194.

Autumn Glory Partners first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $300K in Q4 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Autumn Glory Partners held 680 shares of Amgen worth $246K as of Q2 2026.
Autumn Glory Partners bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
Amgen made up 0.07% of Autumn Glory Partners's portfolio in Q2 2026, its #194 holding.
Autumn Glory Partners first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
Autumn Glory Partners's Amgen position peaked at $300K in Q4 2021.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.